Roadmap
Hiprofeet Roadmap: Our Path to the Future
Last updated
Hiprofeet Roadmap: Our Path to the Future
Last updated
Hiprofeet’s roadmap outlines a clear path to scaling its impact:
Q1 2024: Validated business model and finalized $HPT Tokenomics.
Q2 2024: Deployed Ethereum-based smart contract and launched pre-sale.
Q3 2024: Invested pre-sale funds into platform enhancements and community initiatives.
Q4 2024: Launched Hiprofeet platform with full $HPT-integrated services, including success toolkit.
Q3 2025: Raise $10,000 to develop Version 2 MVP and expand user base.
2026+: Scale globally, enhance token utility, and integrate advanced features like AI-driven analytics.
Hiprofeet has already achieved significant milestones:
Version 1 MVP Tested: Successfully launched and validated with real-world users.
Revenue Generated: NGN 6,000,000 in revenue, demonstrating market demand.
Customer Traction: Onboarded 411 customers, primarily digital product sellers running social media ads.
Pre-sale Allocation: 40% of $HPT Tokens reserved for early adopters, with 30% for community rewards.
Hiprofeet’s revenue model is designed to be flexible, scalable, and user-friendly, keeping costs low while driving sustainable growth. It comprises two streams:
Subscriptions: Users pay recurring fees for access to premium features in the success toolkit, such as advanced analytics, campaign templates, or priority support. This provides predictable revenue and encourages long-term engagement.
Transaction Fees: A small percentage (e.g., 5%) is charged on platform transactions, such as DFY campaign bookings or ad placements. This stream scales with usage, incentivizing Hiprofeet to attract high-value clients and increase transaction volume.